Literature DB >> 20865296

ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphoma: feasibility study.

Thomas C Kwee1, Inge Ludwig, Cuno S Uiterwaal, Henriette M E Quarles van Ufford, Malou A Vermoolen, Rob Fijnheer, Marc B Bierings, Rutger A J Nievelstein.   

Abstract

OBJECT: To determine whether apparent diffusion coefficient (ADC) measurements allow discrimination of normal lymph nodes from lymphomatous lymph nodes, and indolent lymphomas from aggressive lymphomas in patients with non-Hodgkin lymphoma (NHL).
MATERIALS AND METHODS: Eighteen healthy volunteers and thirty-two patients with newly diagnosed NHL (indolent: n = 16; aggressive: n = 16) underwent diffusion-weighted imaging. ADCs of normal lymph nodes were compared to those of lymphomatous lymph nodes, and ADCs of indolent lymphomas were compared to those of aggressive lymphomas. Receiver operating characteristic (ROC) analysis was performed when ADCs were significantly different between two of the aforementioned groups.
RESULTS: ADCs (in 10(-3) mm(2)/s) of lymphomatous lymph nodes (0.70 ± 0.22) were significantly lower (P < 0.0001) than those of normal lymph nodes (1.00 ± 0.15). Area under the ROC curve was 0.865. Sensitivity and specificity were 78.1 and 100% when using an optimal cutoff ADC value of 0.80. On the other hand, ADCs of indolent lymphomas (0.67 ± 0.21) were not significantly different (P = 0.2997) from those of aggressive lymphomas (0.74 ± 0.23).
CONCLUSION: ADC measurements show promise as a highly specific tool for the discrimination of normal lymph nodes from lymphomatous lymph nodes, but appear to be of no utility in differentiating indolent from aggressive lymphomas.

Entities:  

Mesh:

Year:  2010        PMID: 20865296     DOI: 10.1007/s10334-010-0226-7

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  37 in total

1.  Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Taoufik El-Gnaoui; Alexandre Vignaud; Pauline Beaussart; Shih-jui Lin; Karim Belhadj; Pierre Brugières; Eva Evangelista; Corinne Haioun; Michel Meignan; Alain Rahmouni
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

2.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

3.  Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.

Authors:  Mitsuaki Tatsumi; Christian Cohade; Yuji Nakamoto; Elliot K Fishman; Richard L Wahl
Journal:  Radiology       Date:  2005-12       Impact factor: 11.105

4.  Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

Authors:  Y Bastion; C Sebban; F Berger; P Felman; G Salles; C Dumontet; P A Bryon; B Coiffier
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

5.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

6.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

7.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer.

Authors:  Aine Sakurada; Taro Takahara; Thomas C Kwee; Tomohiro Yamashita; Seiji Nasu; Tomohiko Horie; Marc Van Cauteren; Yutaka Imai
Journal:  Eur Radiol       Date:  2009-01-27       Impact factor: 5.315

Review 8.  Non-Hodgkin lymphoma.

Authors:  Linda S Evans; Barry W Hancock
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

9.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

10.  Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient.

Authors:  E J Lee; S K Lee; R Agid; J M Bae; A Keller; K Terbrugge
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

View more
  8 in total

1.  Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.

Authors:  Annalisa Balbo-Mussetto; Chiara Saviolo; Alberto Fornari; Daniela Gottardi; Massimo Petracchini; Annalisa Macera; Chiara Valentina Lario; Teresa Gallo; Corrado Tarella; Stefano Cirillo
Journal:  Radiol Med       Date:  2017-04-18       Impact factor: 3.469

2.  Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Authors:  Hugo J A Adams; Thomas C Kwee; Malou A Vermoolen; Bart de Keizer; John M H de Klerk; Judit A Adam; Rob Fijnheer; Marie José Kersten; Jaap Stoker; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

3.  Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: a pilot study.

Authors:  Marilyn J Siegel; Clint E Jokerst; Dhana Rajderkar; Charles F Hildebolt; Sagun Goyal; Farrokh Dehdashti; Nina Wagner Johnston; Barry A Siegel
Journal:  NMR Biomed       Date:  2014-04-03       Impact factor: 4.044

4.  Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma.

Authors:  Xingchen Wu; Hannu Pertovaara; Pasi Korkola; Prasun Dastidar; Ritva Järvenpää; Hannu Eskola; Pirkko-Liisa Kellokumpu-Lehtinen
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  Whole-body magnetic resonance imaging in paediatric Hodgkin lymphoma - evaluation of quantitative magnetic resonance metrics for nodal staging.

Authors:  Arash Latifoltojar; Paul D Humphries; Leon J Menezes; Athar Haroon; Stephen Daw; Ananth Shankar; Shonit Punwani
Journal:  Pediatr Radiol       Date:  2019-07-22

6.  Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.

Authors:  Dobromila Baranska; Katarzyna Matera; Michal Podgorski; Magdalena Gorska-Chrzastek; Karolina Krajewska; Joanna Trelinska; Piotr Grzelak
Journal:  MAGMA       Date:  2018-11-29       Impact factor: 2.310

7.  Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals.

Authors:  Ricardo Donners; Raphael Shih Zhu Yiin; Dow-Mu Koh; Katja De Paepe; Ian Chau; Sue Chua; Matthew D Blackledge
Journal:  Quant Imaging Med Surg       Date:  2021-08

8.  Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation.

Authors:  L Kurch; R Kluge; O Sabri; L Fischer; S Wendt; H Graf Einsiedel; S Starke; J-S Kühl; H Christiansen; F W Hirsch; I Sorge; C Roth
Journal:  EJNMMI Res       Date:  2021-07-03       Impact factor: 3.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.